Pharmabcine

Pharmabcine is a biotech company in Daejeon, South Korea.

Beyond Innovations For Life

Headquarters
Daejeon
Employees
11–50
Business Model
B2B

About

PharmAbcine is a clinical-stage biopharmaceutical company focused on developing novel antibody therapeutics to address unmet medical needs. The company's pipeline includes olinvacimab, PMC-309, PMC-402, and PMC-403 — candidates targeting cancer and vascular pathways — which are being advanced through Phase 1 clinical trials with the goal of licensing out to global biopharma partners. PharmAbcine leverages its proprietary fully human antibody library and antibody engineering capabilities to create innovative therapeutic antibodies, with a mission of contributing to human health by providing breakthrough treatments to patients worldwide. The company is headquartered in Daejeon, South Korea.

Summary

It lists 11–50 employees.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Pharmabcine on Indexed.vc
<a href="https://indexed.vc/companies/pharmabcine"><img src="https://indexed.vc/api/badge/company/pharmabcine" alt="Pharmabcine on Indexed.vc" width="260" height="76" /></a>